WeVote
Log In

Bill

RB

Bill

S 3047

Establishes requirements to evaluate certain people who are pregnant and who have given birth for preeclampsia.*

2024-2025 Regular Session Introduced by Renee Burgess and 1 co-sponsor

New Jersey requires healthcare providers to screen pregnant people and new mothers for preeclampsia to reduce maternal health risks and complications.

Referred to Senate Budget and Appropriations Committee
#health
0
WeVote Research Nonpartisan
Bill Summary · S 3047

Legislative bill overview

S 3047 mandates clinical evaluation and screening for preeclampsia in pregnant individuals and those who have recently given birth in New Jersey. The bill establishes specific protocols that healthcare providers must follow to identify and manage this serious pregnancy complication, which can pose risks to both mother and child if undetected.

Why is this important

Preeclampsia affects 1 in 25 pregnancies and remains a leading cause of maternal mortality and morbidity in the United States. Early detection and proper management significantly reduce serious complications like stroke, organ failure, and maternal death, making systematic screening a public health priority.

Potential points of contention

  • Healthcare provider burden: Mandatory screening requirements may increase administrative and clinical workload on obstetric practices, particularly smaller practices or those in underserved areas
  • Implementation costs: The bill does not specify funding mechanisms, raising questions about who bears the costs of required evaluations, training, and infrastructure
  • Standardization challenges: Defining consistent evaluation standards across diverse healthcare settings (hospitals, clinics, midwifery practices) could prove complex and create compliance inconsistencies

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.